SKSangeun Kim

Sangeun Kim

*This is an algorithmically generated author record based on publicly available information.

Sangeun Kim has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Treatment of Acne Scars in Asian Patients Using a 2,790-nm Fractional Yttrium Scandium Gallium Garnet Laser

    by Sangeun Kim

    Participants (8 female, 12 male, mean age 26) with skin phototype IV and atrophic acne scars were treated with two sessions of 2,790-nm ablative fractional resurfacing laser at a 6-week interval. Objective and subjective (clinical evaluation by two blinded dermatologists) assessments were obtained at baseline and 1 and 3 months after the final treatment. RESULTS At the 3-month follow-up, 70% of the participants were rated as having at least 50% to 89% improvement of scars. Mild erythema was the most common adverse effect, observed in 30% of participants, but resolved completely in an average of 5 days. CONCLUSIONS Yttrium scandium gallium garnet ablative fractional resurfacing (2,790-nm) appears to be effective and well tolerated for the treatment of atrophic acne scars in Asians. The authors have indicated no significant interest with commercial supporters....


  • Treatment of procedure‐related postinflammatory hyperpigmentation using 1064‐nm Q‐switched Nd:YAG laser with low fluence in Asian patients: report of five cases

    by Sangeun Kim, Kyeong‐Hun Cho

    Summary: Postinflammatory hyperpigmentation (PIH) developing after cosmetic procedures, such as chemical peeling and laser therapies, are always a concern, especially in Asians. Some cases of PIH tend to be spontaneously regressed; however, certain forms of PIH need to be treated with several therapeutic attempts, including bleaching creams, several kinds of Q‐switched lasers, and erbium‐doped fractional photothermolysis system, with various treatment outcomes. A 1064‐nm Q‐switched Nd:YAG laser with low‐fluence therapy is easily applicable, and the therapeutic trial in our case was revealed to have minimal downtime without post‐therapy bleeding or crust formation; the post‐therapy erythema spontaneously resolved within a few hours. The 1064‐nm Q‐switched Nd:YAG laser with low‐fluence treatment should be considered in the treatment of PIH caused by procedures like laser surgery and chemical peeling in Asian patients.


  • Treatment of Facial Postinflammatory Hyperpigmentation with Facial Acne in Asian Patients Using a Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser

    by Sangeun Kim, Kyeong-Hun Cho

    Postinflammatory hyperpigmentation (PIH) due to facial acne commonly occurs in Fitzpatrick skin types IV to VI and can have a considerable effect on quality of life. The sequelae in terms of pigmentation are often the main reason for consulting a dermatologist and take precedence over the acne itself. The purpose of this study was to evaluate a new combined photoacoustic-photothermal low-fluence Q-switched neodymium-doped yttrium aluminum garnet (QSNY) laser in the treatment for facial acne and PIH. Twenty individuals underwent five weekly full-facial treatments using a QSNY laser at 1,064 nm. Another 20 individuals underwent five weekly facial acne treatments by extraction of comedones, and intralesional injections into severely inflamed papules were performed at each treatment session. Clinical assessment scores were determined 1 and 3 months after the last treatment. QSNY laser treatments at 1,064 nm were found to be effective at treating PIH and have an additional effect on concomitant acne lesions. The authors have indicated no significant interest with commercial supporters.


  • Clinical Trial of Dual Treatment with an Ablative Fractional Laser and a Nonablative Laser for the Treatment of Acne Scars in Asian Patients

    by Sangeun Kim, Kyeong-Hun Cho

    Many methods have been proposed for the treatment of acne scars, with variable cosmetic results. Nonablative skin resurfacing is one method that has been proposed. Because of a need for more noticeable clinical improvements, the ablative fractional laser was recently introduced. To reduce complications and improve the results of ablative fractional laser resurfacing by combining this treatment of acne scars with nonablative lasers. A series of 20 patients (skin phototypes IV–V) with atrophic facial acne scars were randomly divided into two groups that received three successive monthly treatments with an ablative fractional laser using high (group A) and low (group B) energy on one facial half and an ablative fractional laser with low energy plus a nonablative resurfacing laser on the other facial half. Patients were evaluated using digital photography at each treatment visit and at 3 months postoperatively. Clinical assessment scores were determined at each treatment session and follow-up visit. Although the use of the ablative fractional laser with high energy resulted in an improvement in patients' acne scars, the combination of ablative fractional laser resurfacing and nonablative laser resurfacing yielded the best results, as assessed in photographs as well as by the overall appearance of the acne scars. With the combination method, fewer complications were observed. The authors have indicated no significant interest with commercial supporters.


    • 11 March 2005
      • Vol. 15  (2) , 92-6

    Treatment of congenital nevi with the Q-switched Alexandrite laser.

    by Sangeun Kim, Won Hyoung Kang

    Q-switched mode lasers have been utilized for treatment of many pigmentary lesions. Because of their short pulse durations (1-100 ns), these lasers selectively destroy pigment laden cells while sparing the surrounding normal tissues. To determine if the Q-switched alexandrite laser (QSAL) is effective in the treatment of congenital melanocytic nevi, 53 patients with these lesions were treated with QSAL; of these, 16 also received CO(2) laser treatment between QSAL treatments. We observed an average improvement score in the 53 treated patients of 2.623 + 1.13, corresponding to a 72% improvement. Treatment with the combination of QSAL and a CO(2) laser resulted in a significant enhancement of improvement score (3.06 +/- 1.18) compared to patients treated with the QSAL alone (2.43 +/- 1.07; p = 0.0393). Complications were mild, with 35 nevi (67.3%) showing textural change of skin after treatment, 2 (3.8%) showing depressed scar formation, and 4 (7.5%) showing hypertrophic changes, while 12 nevi (23%) showed no changes. Hypopigmentation was observed in 16 patients (30%), and hyperpigmentation was observed in 15 patients (28%) 48 weeks after the final QSAL treatment. Repigmentation to a brown to black spot was observed in 44/53 (83%) patients within an average of 5.45 +/- 3.93 months. These results indicate that the QSAL was as effective as other Q switch mode lasers in the treatment of congenital melanocytic nevi, but repigmentation is a problem.